Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
IRWD

IRONWOOD PHARMACEUTICALS (IRWD) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $3.82 -1.3% on the day +115.8% over 12 months 52-week range $1.43 – $5.39

Share price and insider trades

IRWD closeInsider buyInsider sale
0246NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $19,973 on 2025-11-17 · Tammi L GaskinsSold $80,460 on 2026-06-16 · Julie MchughSold $162,914 on 2026-01-05 · Ronald SilverSold $578,063 on 2026-07-07 · Ronald SilverSold $609,951 on 2026-02-23 · Gregory S. Martini, Michael Shetzline, Minardo John, Ronald Silver, Tammi L Gaskins, Thomas A MccourtSold $640,163 on 2026-02-24 · Gregory S. Martini, Michael Shetzline, Minardo John, Ronald Silver, Tammi L Gaskins, Thomas A MccourtSold $20,530,448 on 2026-03-17 · Alexander J Denner
Bought, 12 months$0
Sold, 12 months$22.6M
Insiders buying0
Insiders selling8

IRONWOOD PHARMACEUTICALS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $22.6M of IRWD stock on the open market.

IRWD insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $20K sold (1 trades)Q4 2025Q1 2026: $21.9M sold (15 trades)Q1 2026Q2 2026: $80K sold (1 trades)Q2 2026Q3 2026: $578K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$578K1
Q2 2026—0$80K1
Q1 2026—0$21.9M15
Q4 2025—0$20K1

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 IRONWOOD PHARMACEUTICALS INC insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $22.6M. 3 of 18 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 9SEC Ronald SilverPfo & Pao Sell Plan 127,890313,680 held (−29%) $4.52 $578K -15.5% —
Jun 17SEC Julie MchughDirector Sell Plan 21,571250,749 held (−8%) $3.73 $80K +2.4% —
Mar 17SEC Alexander J DennerDirector Sell 6,725,0009,194,435 held (−42%) $3.05 $20.5M +25.2% —
Mar 17SEC Alexander J DennerDirector Sell 5,8009,188,635 held (−0%) $3.31 $19K +15.4% —
Feb 25SEC Thomas A MccourtCEO Sell 103,5261,489,002 held (−7%) $3.66 $379K +4.4% —
Feb 25SEC Thomas A MccourtCEO Sell 94,7571,592,528 held (−6%) $3.81 $361K +0.3% —
Feb 25SEC Minardo JohnGeneral Counsel Sell 19,053363,886 held (−5%) $3.66 $70K +4.4% —
Feb 25SEC Minardo JohnGeneral Counsel Sell 17,439382,939 held (−4%) $3.81 $66K +0.3% —
Feb 25SEC Michael ShetzlineSvp, Cmo, Head-Res&Drug Sell 17,012521,425 held (−3%) $3.66 $62K +4.4% —
Feb 25SEC Michael ShetzlineSvp, Cmo, Head-Res&Drug Sell 15,570538,437 held (−3%) $3.81 $59K +0.3% —
Feb 25SEC Ronald SilverPrincipal Accounting Officer Sell 12,621252,636 held (−5%) $3.66 $46K +4.4% —
Feb 25SEC Ronald SilverPrincipal Accounting Officer Sell 11,552265,257 held (−4%) $3.81 $44K +0.3% —
Feb 25SEC Gregory S. MartiniCFO Sell 11,457160,601 held (−7%) $3.66 $42K +4.4% —
Feb 25SEC Tammi L GaskinsChief Commercial Officer Sell 11,239213,738 held (−5%) $3.66 $41K +4.4% —
Feb 25SEC Gregory S. MartiniCFO Sell 10,487172,058 held (−6%) $3.81 $40K +0.3% —
Feb 25SEC Tammi L GaskinsChief Commercial Officer Sell 10,287224,977 held (−4%) $3.81 $39K +0.3% —
Jan 7SEC Ronald SilverPrincipal Accounting Officer Sell Plan 35,416276,809 held (−11%) $4.60 $163K -17.0% —
Nov 19SEC Tammi L GaskinsChief Commercial Officer Sell 6,016235,264 held (−2%) $3.32 $20K +15.1% —

Insiders at IRONWOOD PHARMACEUTICALS INC

InsiderBoughtSoldLast filingScore
Alexander J DennerDirector — $20.5M Mar 17, 2026 —
Ronald SilverPfo & Pao — $831K Jul 9, 2026 —
Thomas A MccourtCEO — $740K Feb 25, 2026 —
Minardo JohnGeneral Counsel — $136K Feb 25, 2026 —
Michael ShetzlineSvp, Cmo, Head-Res&Drug — $122K Feb 25, 2026 —
Tammi L GaskinsChief Commercial Officer — $100K Feb 25, 2026 —
Gregory S. MartiniCFO — $82K Feb 25, 2026 —
Julie MchughDirector — $80K Jun 17, 2026 —

IRWD stock: common questions

Are IRONWOOD PHARMACEUTICALS INC insiders buying IRWD stock?

In the past 12 months, 0 insiders reported open-market purchases of IRWD worth $0.

Are IRONWOOD PHARMACEUTICALS INC insiders selling IRWD stock?

8 insiders reported sales worth $22.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is IRWD's 52-week range?

Over the past year IRWD has traded between $1.43 and $5.39. It last closed at $3.82 on Oct 9, 2026.